PAPER Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, Jeng AT, Cooper B, Skorupa T, Carrell D, Levitch D, Hsu S, Choi J, Ryten M, UK Brain Expression Consortium, Hardy J, Ryten M, Trabzuni D, Weale ME, Ramasamy A, Smith C, Sassi C, Bras J, Gibbs JR, Hernandez DG, Lupton MK, Powell J, Forabosco P, Ridge PG, Corcoran CD, Tschanz JT, Norton MC, Munger RG, Schmutz C, Leary M, Demirci FY, Bamne MN, Wang X, Lopez OL, Ganguli M, Medway C, Turton J, Lord J, Braae A, Barber I, Brown K, Alzheimer’s Research UK Consortium, Passmore P, Craig D, Johnston J, McGuinness B, Todd S, Heun R, Kölsch H, Kehoe PG, Hooper NM, Vardy ER, Mann DM, Pickering-Brown S, Brown K, Kalsheker N, Lowe J, Morgan K, David Smith A, Wilcock G, Warden D, Holmes C, Pastor P, Lorenzo-Betancor O, Brkanac Z, Scott E, Topol E, Morgan K, Rogaeva E, Singleton AB, Hardy J, Kamboh MI, St George-Hyslop P, Cairns N, Morris JC, Kauwe JS, Goate AM
SEARCH RESULTS
331159 RESULTS
Blocking BACE—Do Adult Mouse Phenotypes Predict Side Effects?
CONFERENCE COVERAGE 2013-12-13 Conference Coverage Despite Eli Lilly terminating development of its BACE inhibitor LY2886721 (see Jun 2013 news story), the protease remains a popular target among pharmaceutical companies looking for the next Alzheimer's disease therapy. While BACE
Sarah Martindale
London, United Kingdom
Shweta Sonawane
India
Archana S S
Deemed universityBangalore
PAPER Martin LJ, Semenkow S, Hanaford A, Wong M
The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.
Neurobiol Aging. 2014 May;35(5):1132-52. Epub 2013 Nov 16 PubMed: 24325796PAPER Kim SH, Knight EM, Saunders EL, Cuevas AK, Popovech M, Chen LC, Gandy S
Rapid doubling of Alzheimer's amyloid-β40 and 42 levels in brains of mice exposed to a nickel nanoparticle model of air pollution.
F1000Res. 2012 Dec 21;1 PubMed: 24327847PAPER Holland JP, Liang SH, Rotstein BH, Collier TL, Stephenson NA, Greguric I, Vasdev N
Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.
J Labelled Comp Radiopharm. 2014 Apr;57(4):323-31. Epub 2013 Dec 11 PubMed: 24327420PAPER Berk C, Sabbagh MN
Erratum to: Successes and Failures for Drugs in Late-Stage Development for Alzheimer's Disease.
Drugs Aging. 2014 Jan;31(1):81. PubMed: 24327322PAPER Larner AJ
Cerebral mass lesions presenting in a cognitive disorders clinic.
Br J Hosp Med (Lond). 2013 Dec;74(12):694-5. PubMed: 24326718PAPER
Upcoming meetings related to Alzheimer's disease.
J Alzheimers Dis. 2014 Jan 1;38(4) PubMed: 24326610PAPER Smith AD, Yaffe K
Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts.
J Alzheimers Dis. 2014;38(4):699-703. PubMed: 24326609PAPER Achouri-Rassas A, Hadj Fredj S, Mrabet Khiari H, Bibi A, Siala H, Mrabet A, Messaoud T
Association between Alzheimer disease and the-491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population.
Neurochem Res. 2014 Feb;39(2):244-7. Epub 2013 Dec 11 PubMed: 24326531PAPER Janicki SC, Park N, Cheng R, Lee JH, Schupf N, Clark LN
Estrogen receptor β variants modify risk for Alzheimer's disease in a multiethnic female cohort.
J Alzheimers Dis. 2014;40(1):83-93. PubMed: 24326520PAPER Perez FP, Bose D, Maloney B, Nho K, Shah K, Lahiri DK
Late-onset Alzheimer's disease, heating up and foxed by several proteins: pathomolecular effects of the aging process.
J Alzheimers Dis. 2014;40(1):1-17. PubMed: 24326519Current Filters
No filters selected